Karen Amsler

748 total citations
15 papers, 593 citations indexed

About

Karen Amsler is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Karen Amsler has authored 15 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in Karen Amsler's work include Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Karen Amsler is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Karen Amsler collaborates with scholars based in United States, Netherlands and Germany. Karen Amsler's co-authors include Gary J. Noel, Richard Strauß, Rienk Pypstra, Joseph S. Solomkin, M. Heep, Wenchi Shang, A. Simon Lynch, Wenping He, Karen Bush and Todd A. Davies and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karen Amsler

15 papers receiving 575 citations

Peers

Countries citing papers authored by Karen Amsler

Since Specialization

Citations

This map shows the geographic impact of Karen Amsler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Amsler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Amsler more than expected).

Fields of papers citing papers by Karen Amsler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Amsler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Amsler. The network helps show where Karen Amsler may publish in the future.

Co-authorship network of co-authors of Karen Amsler

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Amsler. A scholar is included among the top collaborators of Karen Amsler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Amsler. Karen Amsler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine 2017 ·Clinical and Vaccine Immunology ·Darren Abbanat, Todd A. Davies, Karen Amsler, Wenping He, Kellen C. Faé, Sarah Janssen, Jan Poolman, Germie P. J. M. van den Dobbelsteen	7
2	Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays 2013 ·International Journal of Antimicrobial Agents ·Darren Abbanat, Wenchi Shang, Karen Amsler, (unknown), (unknown), Steven M. Crespo‐Carbone, A. Simon Lynch	31
3	A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation 2012 ·International Journal of Antimicrobial Agents ·Susan Nicholson, Tobias Welte, Thomas M. File, Richard Strauß, Bart Michiels, Pratibha Kaul, Dainius Balis, (unknown), Karen Amsler, Gary J. Noel	120
4	Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus 2012 ·Antimicrobial Agents and Chemotherapy ·Jeffrey Fernandez, Darren Abbanat, Wenchi Shang, Wenping He, Karen Amsler, James Hastings, Anne Marie Queenan, (unknown), (unknown), Robert K. Flamm, A. Simon Lynch	24
5	Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09 2011 ·Journal of Antimicrobial Chemotherapy ·Todd A. Davies, Anne Marie Queenan, Brian J. Morrow, Wenchi Shang, Karen Amsler, Wenping He, A. Simon Lynch, Chris M. Pillar, Robert K. Flamm	80
6	Comparison of Broth Microdilution, Agar Dilution, and Etest for Susceptibility Testing of Doripenem against Gram-Negative and Gram-Positive Pathogens 2010 ·Journal of Clinical Microbiology ·Karen Amsler, (unknown), Barbara D. Foleno, Karen Bush, Robert K. Flamm	14
7	In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone 2010 ·Antimicrobial Agents and Chemotherapy ·Brian J. Morrow, Wenping He, Karen Amsler, Barbara D. Foleno, Mark J. Macielag, A. Simon Lynch, Karen Bush	53
8	Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials 2009 ·International Journal of Antimicrobial Agents ·Todd A. Davies, Wenchi Shang, Karen Amsler, Saralee Bajaksouzian, Michael R. Jacobs, Karen Bush	7
9	Ceftobiprole Activity Against Baseline Pathogens from Recent Pneumonia Trials 2008 ·46th Annual Meeting ·Karen Amsler	2
10	In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections 2008 ·Antimicrobial Agents and Chemotherapy ·Karen Amsler, Todd A. Davies, Wenchi Shang, Michael R. Jacobs, Karen Bush	30
11	P1321 Regional variation in Panton-Valentine leukocidin positivity smong S. aureus isolates in complicated skin and skin structure infections 2007 ·International Journal of Antimicrobial Agents ·Richard E. Strauss, Karen Amsler, (unknown), Karen Bush, Gary J. Noel	2
12	Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria 2007 ·Antimicrobial Agents and Chemotherapy ·Gary J. Noel, Richard Strauß, Karen Amsler, M. Heep, Rienk Pypstra, Joseph S. Solomkin	146
13	Parallel Synthesis of Potent, Pyrazole-Based Inhibitors of Helicobacter pylori Dihydroorotate Dehydrogenase 2002 ·Journal of Medicinal Chemistry ·Tasir S. Haque, Seifu Tadesse, Jovita Marcinkeviciene, Michael J. Rogers, Christine Sizemore, Lisa M. Kopcho, Karen Amsler, (unknown), (unknown), Frank W. Hobbs, Andrew Slee, George L. Trainor, Andrew M. Stern, Robert A. Copeland, Andrew P. Combs	49
14	Effects of Metronidazole, Tetracycline, and Bismuth-Metronidazole-Tetracycline Triple Therapy in the Helicobacter pylori SS1 Mouse Model after 1 Day of Dosing: Development of an H. pylori Lead Selection Model 2002 ·Antimicrobial Agents and Chemotherapy ·Christine Sizemore, Joel Quispe, Karen Amsler, (unknown), (unknown), D. Andrew Stevenson, (unknown), Andrew Slee	9
15	Glutamyl-γ-boronate Inhibitors of Bacterial Glu-tRNAGln Amidotransferase 2001 ·Bioorganic & Medicinal Chemistry Letters ·Carl P. Decicco, David J. Nelson, Ying Luo, (unknown), Kurumi Y. Horiuchi, Karen Amsler, (unknown), Susan Spitz, (unknown), Christine Sizemore, Kelley C. Rogers, Robert A. Copeland, Mark R. Harpel	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact